-Asia News Network A controversy is brewing over a new cure for hepatitis C because it is extremely expensive and patients in middle-income countries like Malaysia will find it way beyond their budget. There are an estimated 400,000 Malaysians with hepatitis C, but this is probably a significant under-estimate since many people are not aware that they have the virus. Worldwide, 170 million people live with the hepatitis C virus (HCV), and every...
More »SEARCH RESULT
For public health as political priority -Sujatha Rao
-The Hindu A systemic reform of the health sector in order to meet the key objectives of equity, efficiency and quality is long overdue. In this, the Central and State governments need to make interventions intelligently, decisively and strategically so that the poor reap the benefits How does Prime Minister Narendra Modi's focus on population, health and subjects like public hygiene, the facilitation of toilets and ensuring preventive health through yoga fit...
More »Toilets on paper -Rukmini S
-The Hindu More than half the households in the country still lack access to sanitation. In its villages, some toilets built under past schemes exist only on paper. In 2019, India will observe the 150th birth anniversary of Mahatma Gandhi, who gave the clarion call, "Clean up your own mess." But even 67 years after Independence, our cities and towns present a sorry picture replete with mounds of garbage, rotting sewers and...
More »Ensuring a healthy start to life -Zakiya Kurrien
-The Hindu The first 1,000 days of life, between a woman's pregnancy and her child's second birthday, are critical for influencing lifelong health and intellectual development of the child The Human Development Report (HDR) released in July 2014 made an important revelation: that India continues to be positioned at 135 in the ranking of 187 countries based on the Human Development Index, and has not moved from where it was positioned the...
More »New drug era -Shamnad Basheer
-The Indian Express Prime Minister Narendra Modi's US visit is likely to throw up highly contentious intellectual property rights issues. Indeed, for the last several years, US drug majors and their European counterparts have lobbied hard to demonise the Indian patent regime. But the government must continue to defend the law and stand its ground. Particularly since our own industrial moguls have caved in and are less vocal about their opposition...
More »